The Wall Street Journal published an article explaining the benefits of pharmacogenomic testing. Pharmacogenomics identifies which inherited genetic variations a person has and predicts how an individual will — or will not — respond to specific medications.

Because everyone responds to drugs differently, testing patients for genetic variation related to drug response could reduce serious adverse drug reactions, and for some people, can explain a lifetime of health mysteries. Many pharmacogenomic testing companies including OneOme in Minneapolis, offer tests aimed at advising providers on what medications may be the best fit for their patients based on their genetic makeup.